Hypoglycemic agents, such as metformin, phenformin, and the AMPK activator acadesine, have strong antitumor effects on T-cell specific PTEN-deficient (tPTEN−/−) lymphoma cells [230] (Figure 3). The gene discussed is PRKAA1; the disease is lymphoma.